These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Intrathecal Pharmacology Update: Novel Dosing Strategy for Intrathecal Monotherapy Ziconotide on Efficacy and Sustainability. Pope JE; Deer TR Neuromodulation; 2015 Jul; 18(5):414-20. PubMed ID: 25708382 [TBL] [Abstract][Full Text] [Related]
9. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial. Wallace MS; Rauck R; Fisher R; Charapata SG; Ellis D; Dissanayake S; Anesth Analg; 2008 Feb; 106(2):628-37, table of contents. PubMed ID: 18227325 [TBL] [Abstract][Full Text] [Related]
10. Considerations and methodology for trialing ziconotide. Burton AW; Deer TR; Wallace MS; Rauck RL; Grigsby E Pain Physician; 2010; 13(1):23-33. PubMed ID: 20119460 [TBL] [Abstract][Full Text] [Related]
11. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain. Wallace MS Expert Rev Neurother; 2006 Oct; 6(10):1423-8. PubMed ID: 17078783 [TBL] [Abstract][Full Text] [Related]
12. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects. Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373 [TBL] [Abstract][Full Text] [Related]
13. Use of Low Dose Ziconotide as First-Line Intrathecal Monotherapy. Prusik J; Argoff C; Peng S; Pilitsis JG Neuromodulation; 2017 Jun; 20(4):386-391. PubMed ID: 27492135 [TBL] [Abstract][Full Text] [Related]
14. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice. Alicino I; Giglio M; Manca F; Bruno F; Puntillo F Pain; 2012 Jan; 153(1):245-249. PubMed ID: 22082570 [TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. Rauck RL; Wallace MS; Leong MS; Minehart M; Webster LR; Charapata SG; Abraham JE; Buffington DE; Ellis D; Kartzinel R; J Pain Symptom Manage; 2006 May; 31(5):393-406. PubMed ID: 16716870 [TBL] [Abstract][Full Text] [Related]
16. Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain. Wermeling DP; Berger JR Pharmacotherapy; 2006 Mar; 26(3):395-402. PubMed ID: 16503720 [TBL] [Abstract][Full Text] [Related]
17. Ziconotide adverse events in patients with cancer pain: a multicenter observational study of a slow titration, multidrug protocol. Dupoiron D; Bore F; Lefebvre-Kuntz D; Brenet O; Debourmont S; Dixmerias F; Buisset N; Lebrec N; Monnin D Pain Physician; 2012; 15(5):395-403. PubMed ID: 22996851 [TBL] [Abstract][Full Text] [Related]
18. [Recommendations for the management of chronic pain by intrathecal ziconotide]. Tronnier V; Hofacker W; Ilias W; Kleinmann B; Koulousakis A; Kress HG; Likar R; Lux EA; Müller-Schwefe G; Schütze G; Uberall M MMW Fortschr Med; 2010 Oct; 152 Suppl 3():106-9. PubMed ID: 21595155 [No Abstract] [Full Text] [Related]
20. Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics. Sanford M CNS Drugs; 2013 Nov; 27(11):989-1002. PubMed ID: 23999971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]